Investment Summary

Easton Capital Investment Group Invests In Kit Check

On July 16, 2013, venture capital firm Easton Capital Investment Group invested in medical products company Kit Check

Investment Highlights
  • This is Easton Capital Investment Group’s 6th transaction in the Medical Products sector.
  • This is Easton Capital Investment Group’s 25th transaction in the United States.
  • This is Easton Capital Investment Group’s 1st transaction in Virginia.

Investment Summary
Date 2013-07-16
Target Kit Check
Sector Medical Products
Investor(s) Easton Capital Investment Group
Deal Type Venture

Target

Kit Check

Alexandria, Virginia, United States
Kit Check is a provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Kit Check was launched in 2012 and is headquartered in Alexandria, Virginia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Easton Capital Investment Group

New York, New York, United States

Investor Investor Investor Investor Investor

Category Venture Capital Firm
Founded 2000
PE ASSETS 200M USD
Size Small
Type Sector Focused
DESCRIPTION

Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York.

DEAL STATS #
Overall 25 of 25
Sector (Medical Products) 6 of 6
Type (Venture) 22 of 22
State (Virginia) 1 of 1
Country (United States) 25 of 25
Year (2013) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-19 bluebird bio

Somerville, Massachusetts, United States

bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. bluebird bio was founded in 1992 and is based in Somerville, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-22 Insmed

Bridgewate, New Jersey, United States

Insmed is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases and protein-based therapeutics. Insmed was founded in 1988 and is based in Bridgewater, New Jersey.

Sell -
Mergr

Product

Company

Legal